CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 153 filers reported holding CONMED CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,109 | -83.0% | 11 | -77.1% | 0.00% | – |
Q2 2023 | $6,522 | +30.8% | 48 | 0.0% | 0.00% | – |
Q1 2023 | $4,985 | +411.3% | 48 | +336.4% | 0.00% | – |
Q4 2022 | $975 | -75.6% | 11 | -78.4% | 0.00% | – |
Q3 2022 | $4,000 | +33.3% | 51 | +27.5% | 0.00% | – |
Q2 2022 | $3,000 | -40.0% | 40 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 40 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | +400.0% | 40 | +400.0% | 0.00% | – |
Q2 2021 | $1,000 | -96.0% | 8 | -98.9% | 0.00% | -100.0% |
Q3 2014 | $25,000 | -3.8% | 698 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $26,000 | -36.6% | 698 | -25.1% | 0.00% | -33.3% |
Q1 2014 | $41,000 | +7.9% | 932 | 0.0% | 0.01% | 0.0% |
Q4 2013 | $38,000 | +18.8% | 932 | 0.0% | 0.01% | +20.0% |
Q3 2013 | $32,000 | +39.1% | 932 | +25.6% | 0.01% | -58.3% |
Q2 2013 | $23,000 | 0.0% | 742 | 0.0% | 0.01% | -33.3% |
Q2 2012 | $23,000 | 0.0% | 742 | 0.0% | 0.02% | -5.3% |
Q1 2012 | $23,000 | – | 742 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |